OMVOH sol inj 200 mg 1 pce

7680689520032 CH-68952 L04AC24 07.15.0.

Active substances:

Mirikizumabum

No images available

Details

Product number
6895203
CPT
-
Packaging group
1
Unit
Injektor(en), vorgefüllt/Pen
Composition
mirikizumabum 200 mg, histidinum, histidini hydrochloridum monohydricum, natrii chloridum, mannitolum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium 2.2974 mg.

Articles (1)

Omvoh 200 mg, solution injectable en stylo prérempli
Lösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
mirikizumabum
200.0 MG Substance Wirkstoff (Principe actif)
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
mannitolum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
2.2974 MG Substance HBESI

Reimbursement information

Public price
CHF 1241.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2026

Authorization holder

Eli Lilly (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
68952
Drug name
Omvoh, solution injectable en stylo prérempli
Galenic form
INLFP
ATC Code
L04AC24
Authorization status
Z
Dispensation category
B
First authorization
30/11/2023
Authorization expiration date
29/11/2028
IT number
07.15.0.
Domain
Human medicine

Packaging details

Description (FR)
OMVOH sol inj 200 mg 1 pce
Description (DE)
OMVOH Inj Lös 200 mg 1 Stk
Market launch
01/08/2026
Narcotic (BTM)
No

Other packaging sizes

OMVOH sol inj 100 mg/ml stylo pré 2 x 1 ml
2 INJ
GTIN: 7680689520018
View
OMVOH sol inj 100 mg + 200 mg stylo pré 1+1 pce
1 + 1 INJ
GTIN: 7680689520025
View
Buy us a coffee Explore the data